Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · Real-Time Price · USD
0.2971
+0.0060 (2.06%)
At close: Feb 18, 2026, 4:00 PM EST
0.3166
+0.0195 (6.56%)
Pre-market: Feb 19, 2026, 8:15 AM EST

Cue Biopharma Revenue

Cue Biopharma had revenue of $2.15M in the quarter ending September 30, 2025, a decrease of -35.58%. This brings the company's revenue in the last twelve months to $7.10M, down -25.51% year-over-year. In the year 2024, Cue Biopharma had annual revenue of $9.29M with 69.16% growth.

Revenue (ttm)
$7.10M
Revenue Growth
-25.51%
P/S Ratio
3.82
Revenue / Employee
$173,171
Employees
41
Market Cap
27.11M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20249.29M3.80M69.16%
Dec 31, 20235.49M4.25M340.96%
Dec 31, 20221.25M-13.70M-91.67%
Dec 31, 202114.94M11.79M373.68%
Dec 31, 20203.15M-304.01K-8.79%
Dec 31, 20193.46M2.32M202.67%
Dec 31, 20181.14M--
Dec 31, 2017---
Dec 31, 2016---
Dec 31, 2015---